Message Board

  • First name*
  • Last name*
  • Email*
  • Mobile*
  • Company/Organization name*
  • Company/Organization type*
  • Department*
  • Job title*
  • How did you hear about us?*
  • Product*
  • Your message
  • Verification Code*

Message Board

  • First name*
  • Last name*
  • Email*
  • Mobile*
  • Company/Organization name*
  • Company/Organization type*
  • Department*
  • Job title*
  • How did you hear about us?*
  • Your message*
  • Verification Code*
2023-05-09

Connecting with OpenAI, AlphaPLife Sciences Opens ChatGPT Function for Digitalization in Clinical Trials

May 9, 2023 — Singapore-based AlphaPrime Life Sciences (referred to as "AlphaPrime") announced the official integration of their clinical research cloud platform, AuroraPrime, with OpenAI's technology. This integration has enabled the practical application of ChatGPT in the digitalization and intelligence of clinical research. AlphaPrime has already begun exploring and expanding the application scenarios with several well-known innovative drug development companies. Additionally, AlphaPrime actively tests and fine-tunes the performance and effectiveness of various renowned AGI models in similar contexts, accelerating the exploration of large language models like ChatGPT in the field of clinical research.

Learn More
2023-04-14

AlphaLife: Using AI to turbocharge clinical trial processes

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s life science arm) and the Engineering Site Lead of Google Shanghai. Sharon is an IT veteran with 20+ years of rich experience in the industry, 15 of which were gained at Google. Sharon earned her bachelor’s degree in automation from Shanghai Jiaotong University, and her master’s degree in computer science from Texas A&M University.

Learn More
2023-04-12

AlphaLife Sciences and Simcere Zaiming Collaborate to Digitize Clinical Trial Documents

On April 12, 2023 — AlphaPrime Life Sciences (hereinafter referred to as "AlphaPrime" ) announced its partnership with Simcere Zaiming, an innovative oncology drug company under the Simcere Pharmaceutical Group, to successfully deploy the AuroraPrime Create system (hereinafter referred to as "Prime Create") for clinical trial document generation at the end of March. The system will be used for clinical trial protocol design and CSR (Clinical Study Report) writing, aiming to empower Simcere Zaiming's medical team to improve content writing and team collaboration efficiency, construct an enterprise-level clinical trial knowledge base, and realize the knowledge accumulation and digitization of trial documents.

Learn More
2023-04-06

AlphaLife Sciences Becomes RemeGen's Strategic Partner in Clinical Research Informationization

On April 6, 2023 — AlphaPrime Life Sciences Group (hereinafter referred to as "AlphaPrime"), announced in Shanghai that it has officially become a strategic partner for clinical research informationization with RemeGen Co., Ltd. (hereinafter referred to as "RemeGen"). As a leading domestic biopharmaceutical company, RemeGen will widely adopt the AuroraPrime clinical research platform from China to support the R&D pipeline of clinical trials, while AlphaPrime will fully support RemeGen's exploration and implementation of clinical research informationization to accelerate innovation.

Learn More
2023-03-30

AlphaLife Sciences Collaborates with CSPC to Explore Enterprise-level Intelligent Medical Writing System

On March 30, 2023 — AlphaPrime Life Sciences Group (hereinafter referred to as "AlphaPrime"), announced its collaboration with CSPC Pharmaceutical Group Co., Ltd (referred to as "CSPC"), one of China's leading innovative pharmaceutical companies, to officially launch the AuroraPrime Create (referred to as "Prime Create"), an intelligent clinical research document generation system. CSPC will fully utilize the system to write clinical research protocols and CSR (clinical study reports) to improve content writing, cross-team collaboration, and approval process efficiency, achieve digitization and structuring of document content, establish an enterprise-level content knowledge base, and realize comprehensive knowledge accumulation and application for innovative research and development.

Learn More
2023-03-10

AlphaLife CEO, Ms. Xiao Chen, Selected as One of Forbes China's Top 20 Promising Businesswomen in 2023

AlphaPrime Life Sciences, a company focused on the intelligent clinical research platform in the life sciences field, announced that its CEO, Ms. Xiao Chen (Sharon Chen), has been selected as one of Forbes China's Top 20 Promising Businesswomen for 2023. The list recognizes women who have made significant contributions to their respective industries and have demonstrated strong growth potential.AlphaPrime Life Science, a company focused on the intelligent clinical research platform in the life sciences field, announced that its CEO, Ms. Xiao Chen (Sharon Chen), has been selected as one of Forbes China's Top 20 Promising Businesswomen for 2023. The list recognizes women who have made significant contributions to their respective industries and have demonstrated strong growth potential.

Learn More

Improve the efficiency of clinical research and development and
bring innovative products to market faster.

CONTACT US

AI Specialist

Shanghai|Engineering|Published 2023-06-02

Responsibilities

1. Engage in AI research and development in the field of clinical and biomedical informatics, including data collection, algorithm research, and model building.

2. Explore innovative applications of AI and be responsible for the application development of NLP technology in specific business scenarios.

3. Build machine learning platforms and frameworks, including algorithm implementation and system development.

4. Keep up with the latest developments in cutting-edge technologies in the industry and integrate them into the existing technical system to continuously enhance the platform's capabilities and meet business needs.

5. Provide insights and take the lead in implementing AI initiatives based on practical application products and scenarios within the company.

Job Requirements

1. Bachelor's degree or above in computer science or a related field, with at least five years of experience in AI research and development. In-depth research in natural language processing or computer vision, solid theoretical foundation, good mathematical and statistical knowledge, and programming skills are required.

2. Practical experience in implementing AI applications, preferably with experience in building from scratch and continuous optimization.

3. Familiarity with cutting-edge research in natural language processing, extensive research experience, and preferred experience in training and applying large-scale language models.

4. Proficiency in various machine learning and deep learning algorithms and their application scenarios.

5. Familiarity with at least one machine learning framework such as TensorFlow, PyTorch, scikit-learn, etc.

6. Strong innovation spirit and scientific research capabilities, good information search, literature reading, and algorithm implementation skills.

7. Strong documentation skills and the ability to communicate effectively with technical teams and management.

Apply Now